COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma

DSpace Repository

COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma

Author: Berking, Carola; Livingstone, Elisabeth; Debus, Dirk; Loquai, Carmen; Weichenthal, Michael; Leiter, Ulrike; Kiecker, Felix; Mohr, Peter; Eigentler, Thomas K.; Remy, Janina; Schober, Katharina; Heppt, Markus V.; von Wasielewski, Imke; Schadendorf, Dirk; Gutzmer, Ralf
Tübinger Autor(en):
Leiter-Stöppke, Ulrike
Published in: Cancers (2023), Bd. 15 (18), Article 4436
Verlagsangabe: Basel : Mdpi
Language: English
Full text: http://dx.doi.org/10.3390/cancers15184436
ISSN: 2072-6694
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)